Clinical Trial Update: The Effect of Dapagliflozin on Weight Loss in Obese Adults Without Diabetes [Phase 4]

View source ↗

Summary

This clinical trial update reports on a Phase 4 study examining the effect of dapagliflozin on weight loss in obese adults without diabetes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Drugs mentioned

• Dapagliflozin (dapagliflozin)

Snippet

Sponsor: Oman Ministry of Health | Conditions: Obesity, Dapagliflozin Adverse Reaction | Phase 4 | Status: ACTIVE_NOT_RECRUITING